Skip to main content

Stem Cell Information

News Items

Latest News from MEDLINEplus Health Information


  • National Human Neural Stem Cell Resource:

    The National Human Neural Stem Cell Resource (NHNSCR, is pleased to announce that they have created an induced pluripotent stem cell (iPSC) biorepository and now have available dozens of fibroblast and iPSC lines derived from patients with idiopathic autism as well as controls and patients with FMR1 gene mutations (both full- and pre-mutations as well as isogenic derivations). Neural stem cells that we have differentiated from these lines are also available. Moreover, full clinical information for each of the lines is available.

    All of the cultures are established under an NIH grant (R01HD059967), entitled "An Open Repository of Autism iPSCs and their derivatives". This effort is in close collaboration with Dr. Randi Hagerman of the UCDavis MIND Institute.

    In addition to acting as a biorepository for cell lines, the NHNSCR also acts as a training facility, bringing in scientists who wish to use these new cell lines in their research and giving them the essential skills to do so. Two recent publications detail the methods that our laboratory uses: Schwartz, PH, and Wesselschmidt, RW, eds., Methods in Molecular Biology, 767:1–461, 2011, Human Pluripotent Stem Cells—Methods and Protocols; and Stover, et al., Journal of Neuroscience Research, 91(10):1247–62, 2013, Process-Based Expansion and Neural Differentiation of Human Pluripotent Stem Cells for Transplantation and Disease-Modeling.

    For more information, please e-mail Dr. Phil Schwartz at or visit our web site at

  • Request For Information—National Cord Blood Inventory (July 08, 2013)



  • NIH appoints Director of Intramural Center for Regenerative Medicine (August 3, 2011)
  • Pluripotent Stem Cells in Translation: Early Decisions: The National Institutes of Health and the Food and Drug Administration are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. The first two day workshop, "Pluripotent Cells in Translation: Early Decisions," was held on March 21 and 22 at Lister Hill Auditorium on the NIH campus in Bethesda, Maryland.
    • The first day (Videocast) covered pluripotency and its challenges, sources of pluripotent cells, and stem cell banks;
    • the second day (Videocast) covered making pluripotent stem cells into a product, product characterization, and emerging technologies.
    The meeting included participants from industry, academic and clinical scientists, the FDA, and the NIH. (April 1, 2011)






Archives (1999–2005)